Skip to main content
Category

Champions

Our Hero Augie Nieto ♥️ February 15, 1958 – February 22, 2023

By Champions 4 Comments

Augie Nieto was our hero. 
 
He inspired us, made us laugh, and made us cry. He taught us that when life hands you unspeakable challenges, what really matters is surrounding yourself with people who love you, and a cause you believe in. He was passionate about finding a cure for ALS, and we are proud to be “Augie’s team”.
 
Augie passed peacefully yesterday surrounded by his beloved wife, Lynne, his family and loved ones.
 
Augie wrote:
 
Please keep me in your hearts…please help continue the progress of Augie’s Quest to Cure ALS. Please help Lynne to carry on the mission – the second finest achievement of my life. Because I will be in your heart, I will get to experience the joy when we discover a cure.

 
Augie was a visionary – an icon in the fitness industry, and a powerful force in the ALS space. He was the Co-Founder and retired CEO of Life Fitness, Chairman and Co-Founder of Augie’s Quest to Cure ALS, and the Chairman of the ALS Therapy Development Institute. He was a beloved husband, father, brother, son, mentor, and friend. Under his leadership, almost $200 million was raised for ALS research. More importantly, Augie was directly responsible for countless advancements and changing the landscape of this horrific disease that ultimately took him just after his 65th birthday.
 
We were proud to fight with Augie and Lynne to transform the way ALS research is funded, approaching it in unprecedented ways. We will diligently work beside his beloved wife in Augie’s honor and memory to find a cure for ALS.
 
Augie wrote:
 
I know that my fight is not over. I have battled ALS for almost 18 years. Physically, ALS has finally taken my body, but my battle to rid the world of this insidious disease will continue.

 
We love you Augie. We’re with you, Lynne.
 
Your Augie’s Quest Team
 
Shannon, Gretchen, Kelly, Angel and Kelsey

Nancy

Nancy Sallaberry

By Champions One Comment

After a courageous, nearly eight-year battle with ALS, Menlo Park resident Nancy Sallaberry passed peacefully in her home on December 18, 2022. Her devoted husband of 38 years Paul Sallaberry; her three sons Marc, Luc, and Daniel Sallaberry; daughter-in-law Brittany Sallaberry, and grandson Chase, were by her side.

Nancy is survived by her three treasured siblings: brother Ron Williams and his wife Joyce; sister Victoria Evans; and brother Reese Williams and his wife Fran. Nancy also was the beloved sister-in-law of Denise Sallaberry and her husband Peter Wilk, and Jack Sallaberry and his wife Sue, as well as a wonderful aunt to many nieces and nephews.

Nancy was born in Marin County in 1955 to the late Reese and Marge Williams; the family later moved to Saratoga, Calif. where Nancy and her siblings grew up. At Saratoga High School Nancy excelled at five sports, reigned as homecoming queen, and made dear, lifelong friends.  She then attended the University of California, Davis, where she played intercollegiate volleyball and earned a Bachelor of Science degree in Dietetics, complementing her already outstanding culinary skills.  It was at UC-Davis that she met Paul.

Nancy worked for several years in the tech industry at Triad Systems, but she found her true calling as a mother. She was devoted to her three sons and a tireless volunteer in their school and sports programs. Nancy preferred to work behind the scenes, and she was an unsung hero bringing creativity, attention to detail, and 110% effort to any project aimed at enriching an experience for young people in the community.

Nancy also had a lifelong passion for sports and the outdoors. She was a proud and devoted soccer mom, a faithful Giants fan, and a gifted tennis player whose senior doubles team twice reached the USTA’s National Finals. She delighted in fishing and enjoying nature with her boys in Northern California mountain areas such as the Trinity Alps and Hat Creek.

Nancy’s gentle and understanding nature, her deep loyalty, her lively sense of humor, and her sparkling smile were a gift to everyone she knew.  She found so many ways to show love to family and friends, whether with a wonderful meal, a supportive shoulder, the perfect gift, or a wry practical joke.  Not only did Nancy navigate ALS with great dignity, she became a trusted friend and resource to others newly diagnosed with the condition. There is a celebration of Nancy’s life planned for the spring.  The family respectfully requests that anyone interested in honoring Nancy consider a gift to Augie’s Quest, a foundation dedicated to supporting research to cure ALS (https://give.augiesquest.org/NancySallaberry).

Read

Related

Nancy Sallaberry

Nancy Sallaberry

The Crawford Charity Golf Tournament raises over $226,000 for ALS Research

By Champions, Fundraising Events No Comments

Thanks to the Crawford Family for choosing Augie’s Quest to Cure ALS as the beneficiary of their 2022 golf outing in August. Today, proceeds of $226,295 were granted to fund the Augie’s Quest to Cure ALS Translational Research Center at the ALS Therapy Development institute. 

These funds are part of a larger $5.8 million grant from Augie’s Quest to ALS TDI through 2024 that was established to fund the discovery of new candidate drugs to slow, stop, or even reverse ALS disease progression. It will help to strengthen existing and future research efforts by aiming to dissect mechanisms of clinical ALS, and use the knowledge to develop new, more powerful drug discovery platforms and facilitate more effective drug development for ALS. 

“We’re grateful to the Crawford family for their dedication to funding ALS research,” wrote Augie Nieto, Chairman of Augie’s Quest to Cure ALS. “We know ALS is curable, and the more champions that support our critical mission, the closer we will get to a cure.”

Sponsors from the tournament included the San Francisco Giants, BiRite Foodservice Distributors, Fragomen, Wasserman, the Brandon Crawford Baseball Camp, the Heller Family, the San Francisco 49ers, Pure Storage, Bitwise, Holmes Helping Hands, the Golden State Warriors and Harmony Capital, LLC.  Special thanks to Augie’s Quest to Cure ALS board member Paul Sallaberry and his wife, Nancy, for their sponsorship and involvement in the tournament.  

The highlight of the event was the engagement from those living with ALS.  Thank you to Osiel Mendoza for sharing his story Read it here

Augie’s Quest to Cure ALS granted $159,122 to the ALS Therapy Development Institute through Cure ALS Golf Classic

By Champions No Comments

August 26, 2022: Augie’s Quest to Cure ALS granted $159,122 to the ALS Therapy Development Institute today. Special thanks to Scott Cameron, recipient of the Phil Green award and chairman of the Cure ALS Golf Classic, for playing a key role in raising these research funds, which are granted in his honor. Scott is a member of the Augie’s Quest to Cure ALS Leadership Council and works tirelessly to find treatments and a cure in honor of his late father, Sandy, who had ALS.

“Thank you to Scott Cameron for sharing our Quest to find a cure for ALS, and his continued leadership,” said Augie Nieto, Chairman of Augie’s Quest to Cure ALS.  “With warriors like Scott and his family, we’re closer than ever to a cure.  We’re proud to provide these funds to ALS TDI in honor of the great volunteer work being done by Scott Cameron ,Phil Green and the dedicated event committee.”

These critical funds support the Augie’s Quest Translational Research Center at ALS TDI which was established to better understand the mechanisms of how amyotrophic lateral sclerosis (ALS) affects the body and use the knowledge to develop new, more effective treatments for the disease. These funds are part of a larger $5.8 million grant from Augie’s Quest to ALS TDI through 2024 that was established to fund the discovery of new candidate drugs to slow, stop, or even reverse ALS disease progression.

The Cure ALS Golf Classic has raised more than $1 million for ALS research. 

Augie's Quest logo

ALS Community Comes Together in Unprecedented Fashion To Urge Congress To Pass Critical Access To Disability Benefits Bill

By Champions

FOR IMMEDIATE RELEASE

Sept. 15, 2020

 

ALS Community Comes Together in Unprecedented Fashion To Urge Congress To Pass Critical Access To Disability Benefits Bill

Twenty ALS Advocate Groups Coordinate to Attain More than 360 Co-Sponsors

in both the House and Senate

 

WASHINGTON – This week, twenty ALS advocacy groups collaborated together to thank the more than 360 Congressional members from across the aisle who have co-sponsored H.R. 1407 and S. 578, which would extend Social Security Disability Insurance (SSDI) benefits for patients living with ALS. The ALS community is now calling on Congress for swift passage of H.R. 1407 and S. 578.

 

The legislation was introduced 19 months ago, but the coordinated campaign among local, regional and national ALS organizations drove progress in the past six months to attain Congressional support. The passing of the bill will provide ALS patients and their loved ones access to SSDI benefits without having to wait five months from the time of diagnosis – an eternity within the two-to-five-year life expectancy of the disease.

 

The effort was sustained by members of the ALS community who worked with Congress, including:

 

  • ALS Hope Foundation
  • ALS ONE
  • Answer ALS
  • Augie’s Quest to Cure ALS
  • Brigance Brigade
  • Compassionate Care ALS
  • Every90Minutes Foundation
  • Everything ALS
  • Hope Loves Company
  • I AM ALS
  • Joe Martin ALS Foundation
  • Les Turner ALS Foundation
  • A Life Story Foundation
  • Live Like Lou
  • Muscular Dystrophy Association
  • The Northeast ALS Consortium (NEALS)
  • The Project ALS Therapeutics Core at Columbia
  • Team Stevens Nation
  • Team Gleason
  • Your ALS Guide

 

 

The ALS community is grateful to each Representative and Senator supporting H.R. 1407 and S.578 during this critical moment for our nation. ALS is an enormous financial burden and it is crucial those living with ALS and their families have as much support as possible. Now, more than ever, it’s imperative Congress passes H.R. 1407 and S. 578 and sends it to the President’s desk for his signature.

 

About ALS

ALS is a disease that attacks cells in the body that control movement. It makes the brain stop talking to the muscles, causing increased paralysis over time. Ultimately, ALS patients become prisoners within their own bodies: unable to eat, talk, breathe or move on their own. Their mind, however, often remains sharp so they are aware of what’s happening to them. ALS will affect 1 in 300 people in our lifetimes, and patients usually have no more than two to five years to live following diagnosis.

Augie's Quest logo

Acquisition of Anelixis Therapeutics Fuels Hopes for ALS

By Champions

Acquisition of Anelixis Therapeutics Fuels Hopes for ALS

 

FOR IMMEDIATE RELEASE

ORANGE COUNTY, Calif. SEPTEMBER 15, 2020 Anelixis Therapeutics, the for-profit clinical-stage development company that advanced the drug AT-1501 to clinical trial, announced on Monday, September 14, that they have been acquired by Novus Therapeutics. Through this acquisition, AT-1501 is expected to advance to the next stage of clinical development, a phase 2 trial in ALS.

Augie Nieto, the-co-founder and Chairman of Augie’s Quest to Cure ALS also serves as Chairman of the ALS Therapy Development Institute, who invented AT-1501.  Augie was also a founding board member of Anelixis.

“When we started Augie’s Quest to Cure ALS in 2005, we knew our best chance of fueling a cure and treatments for this devastating disease was to find the best scientific partner – which we did in ALS TDI,” said Augie Nieto.  “Solid leadership drives success, and we couldn’t be more excited about the acquisition of Anelixis by Novus Therapeutics.  We need stronger treatment options for ALS, and I’m confident this is a critical step to reach that goal,” he added.

AT-1501 is an investigational antibody that targets the CD40 ligand (CD40L), a protein present at the surface of some white blood cells that is involved in inflammation. In ALS, blocking CD40L activation decreases inflammatory responses implicating CD40L in neurodegeneration.

AT-1501 was invented by the ALS Therapy Development Institute with funding from Augie’s Quest to Cure ALS, and in 2019, Anelixis Therapeutics successfully completed phase 1 clinical trials for AT-1501 as a treatment for ALS. The study, involving both healthy volunteers and participants with ALS, showed that AT-1501 was well tolerated at all doses tested and that the pharmacokinetic properties of AT-1501 were typical for an IgG1 antibody therapeutic.

AT-1501 is being developed by Novus Therapeutics as a potential treatment in renal transplantation, islet cell transplantation, autoimmune nephritis, and ALS . ALS will be the first of these indications to begin enrolling for Phase 2 trials, and enrollment is expected to begin by the end of 2020.

ALS TDI’s CEO, Steve Perrin, PhD stated, “The partnership between ALS TDI and Anelixis to move AT-1501 from preclinical to clinical development has been very exciting. This unique business relationship truly demonstrates the ability of a non-profit to leverage philanthropic support, like that from Augie’s Quest to Cure ALS,  to move a promising treatment into clinical trials. As we discover more potential treatments for ALS, we will lean into these experiences as we look to advance new leads into human clinical testing.”

Steve Perrin will serve as President and Chief Scientific Officer of Novus Therapeutics, and also serve on the board.  Walter Ogier, the Chairman of the Board of Anelixis, will take the second board seat.  “I was so impressed with Walter’s performance as Chairman of Anelixis, that I believed it was critical that Steve and Walter continue to serve on the board due to their decades of experience,” added Nieto.

AT-1501 is the first potential treatment to be invented at ALS TDI and successfully advanced through a Phase 1 clinical study. However, scientists at ALS TDI are continuing to work to find more potential treatments for people with ALS. With continued funding, ALS TDI hopes to develop more promising treatments that can be brought through trial and eventually become available for people with ALS.  Augie’s Quest to Cure ALS is committed to continue to fund the important science being done at ALS TDI.

About Augie’s Quest to Cure ALS

 Augie’s Quest to Cure ALS is dedicated to changing the experience of people living with ALS. We raise the funds and awareness urgently needed to advance cutting-edge research, fast-track effective treatments, and ultimately, find a cure for this devastating disease. Augie’s Quest was founded in 2005 by Augie Nieto, the successful fitness industry mogul behind Lifecycle and Life Fitness and whose life story was recently chronicled in the award-winning film, Augie. With Augie’s Quest, ALS doesn’t stand a fighting chance. Because ALS isn’t incurable, it’s only underfunded. Please join our quest at www.augiesquest.org.

About AT-1501

AT-1501 is a humanized IgG1 anti-CD40L antibody with high affinity for CD40L, a well-validated target with broad therapeutic potential. The CD40/CD40L pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation. In a Phase 1 safety study of healthy volunteers and patients with ALS, AT-1501 was well tolerated at all doses tested.

 

About Anelixis Therapeutics

 Anelixis Therapeutics, Inc. was a clinical stage, privately held biotechnology company developing treatments for patients with neurodegenerative disease, people requiring an organ or cell based transplant, as well as people with an autoimmune disease. Since its founding in 2015, Anelixis Therapeutics has optimized and validated a cGMP manufacturing process for AT-1501, confirmed exceptional activity in preclinical disease models, demonstrated safety and tolerability in humans

The development of AT-1501 has been funded with support from The ALS Therapy Development Institute, Augie’s Quest to Cure ALS, The ALS Association, ALS One, ALS Finding a Cure, and The Congressionally Directed Medical Research Program. Anelixis also conducted several private placement rounds including a round led by  Noble Capital Markets, Inc. (Noble), an investment bank headquartered in Boca Raton Florida, who acted as the exclusive placement agent in a private placement financing round, and a financing round was also led by the Biotechnology Value Fund, L.P. and other affiliates of BVF Partners L.P. (“BVF”).

For more information, please visit the company’s website at www.AnelixisTherapeutics.com.

 

 

 

 

 

 

 

 

 

Dancing at the bash

The Good Days Will Always Outnumber the Bad

By Champions

A Veteran Talks

“Hey kid, the good days will always outnumber the bad,” he said to me with a kind smile and wink. We were sitting side by side in the infusion center at Massachusetts General Hospital receiving therapy back in early 2002. Bill and I were on the same treatment rotation and had become friends. He had been front and center during the Cuban missile crisis in the Navy. I was currently on active duty as a Navy Nurse in CT. He was receiving the treatment appropriate for his neuro muscular condition. I was receiving it on the slim chance it would help, since one of my lab values was unusual when all other evidence pointed directly to the inescapable ALS. I was 26 years old, scared about the future, sitting next to my fellow veteran, and found his words were of great comfort to me.

Eighteen years later, I find that the good days have always outnumbered the bad and I suspect it will continue to be this way. The bad days have included the shattered dream of having children of my own as my siblings and friends continued “normal life.” The bad days also included the end of a young marriage in a bitter divorce. But, as you know, ALS is relentless in breaking bodies and hearts.

Today, we all find ourselves in unprecedented, turbulent times. This can be very unnerving, especially, when combined with ALS. My partner and I went into strict isolation in mid-March and spent three months together 24/7 as he was my only caregiver. We struggled through the social isolation, my guilt about depending completely on him and figured out how to settle into a new type of lifestyle. Our days now have a simpler rhythm. Watching flowers blossom is a big treat! The garage is not for my van anymore. It is set up for socializing with neighbors and family at a safe distance complete with a screen tent, carpet, lawn chairs and flower pots to line the entrance!

During these turbulent, changing times, I have some good news to share. My partner, Leif, and I got engaged a few weeks ago and are planning a very small ceremony October 3rd! WHAT??  Who marries a 44 year old woman who has ALS? Evidently, Leif does. We have been living together for eight years and he figured if we could be together 24/7 for three months and still like each other, we might as well give marriage a shot.

I pray that as we all find new paths forward, excavating our former lives, positive things will surface. I am pleased to learn that ALS clinical trials have used the past few months to pivot how trials are run. They are now maximizing the use of video appointments to gather information and reduce in person visits. The field has also shifted to investigating breathing measurements that can be taken at home and doing safety labs locally. These changes bring the possibility of including more people in ALS trials by reducing some of the barriers.

We will all continue to have bad days. Life is just like that. My wish for you is that your good days always outnumber the bad. Keep your heads up and seek out the positive.

Sending my love from NH,

Ellen Corindia

3/13/15
Los Angeles, CA
ALS.net
BASH for Augie’s Quest
Photo Credit: Marvin Steindler/Steve Cohn Photography
© 2015 Steve Cohn Photography
www.stevecohnphotography.com
(310) 277-2054

Augie's Quest logo

COVID-19 Resources for the ALS Community

By Champions

If you or someone you know has ALS and is currently experiencing symptoms of COVID-19, please contact your healthcare provider immediately.  

With the recent assignation of COVID-19 as a pandemic by the World Health Organization, we are sharing pertinent information with the ALS community to understand the risks and impact of SARS-CoV2. Please note that per the CDC, this is a rapidly evolving situation, and the CDC will continue to share updates daily.

While there is currently no evidence to show that patients with ALS are uniquely sensitive to the virus, individuals with respiratory health issues, chronic medical conditions such as heart disease, diabetes or lung disease, and those who are elderly may be at a higher risk for experiencing COVID-19 severely.

Prevention & Management: 

In addition to following the CDC recommendations for the prevention and management of COVID-19, we recommend asking your ALS clinic care team whether they recommend an in person or tele-visit. You may also find the Les Turner ALS Foundation’s care recommendations for respiratory issues helpful.

The ALS Association has published  “ Tips to Help the ALS Community Plan Ahead During the COVID-19 Pandemic”  developed for people with ALS and their families, to help them advocate effectively with healthcare providers, healthcare facilities, emergency medical technicians and medical transport systems to ensure fair and appropriate treatment during the COVID crisis.

Information Related to Clinical Trials:

If you are currently participating in a clinical trial, contact your trial care team to determine if there are any changes to protocol or timeline.

In an Emergency Situation:

If you are in need of assistance from an emergency medical technician (EMT) please reference this document from I AM ALS for helpful information to provide to them and emergency room staff regarding additional precautions to take when caring for ALS patients.

The CDC and other health professionals are learning more about COVID-19 every day. While the possibility of contracting a contagious disease is scary, it is important to stay calm and follow recommended prevention and management strategies. Please continue to check the CDC’s website for the most up to date information about COVID-19 in the US.

Support Resources

Augie’s Quest, Team Gleason, Les Turner ALS Foundation, I AM ALS, LiveLikeLou, Hope Loves Company, The Joe Martin ALS Foundation, The Brigance Brigade Foundation and others across the ALS community are banding together to support ALS families during this time. We have compiled a list of resources that are providing assistance to families with ALS who are affected by COVID-19. 

Financial Assistance & Volunteer Support:

  • The Healthwell Foundation is offering a small grant to help people cover costs related to COVID-19 such as delivery of food, medications, transportation and telehealth visits. Check out the eligibility details here and call (800) 675-8416 to apply over the phone.
  • The Susie Foundation in Connecticut has introduced a Good Neighbors program that will connect families affected by ALS with volunteers who will run 1-2 critical errands for them per week. They are also repurposing their Flex Grant program to provide emergency funding to families who are struggling with unexpected expenses due to the spread of COVID-19. Learn more about their programs and how to apply here
  • The Les Turner ALS Foundation in the Chicagoland area is providing emergency relief funding. Learn more here
  • The LiveLikeLou Foundation has launched the Great LiveLikeLou Outdoor Clean-Up for ALS Families to match ALS Families with Phi Delts to offer volunteer support to ONLY 1) outdoor projects and chores, 2) no personal contact and 3) CDC-allowable interactions.  This is a “one-time” or “occasional” support for ALS Families so that the college students in particular can meet their families’ expectations for support.

Equipment:

  • Your ALS Guide is donating 5,000 FDA-approved surgical masks to people living with ALS, caregivers, and ALS professionals in the United States. People can request masks at Masks for the ALS Community and they will be mailed out within 48 hours.
  • Every 90 Minutes, Team Gleason and Evergreen Circuits are providing ventilator filters from Philips Respironics to ALS patients who are unable to get it through a DME supplier. Click here to apply
  • Team Gleason is continuing to provide all of its services to people living with ALS, with the exception of adventures which have been suspended. Learn about how they may be able to help you and apply for assistance here
  • Acknowledging that there may be a shortage of some supplies, Respiratory Quality Services researched ways to clean your breathing device accessories. You can read them here. Be sure to consult with your Respiratory Therapist on these guidelines.

Veterans:

  • The House Committee on Veterans’ Affairs has helpful information on COVID-19 resources for veterans with ALS here.

Virtual Engagement:

  • Hope Loves Company is going virtual! Check out their site for updates on online activities and their upcoming Pen Pal program for children, teens and adults. 
  • Team Gleason and The Center for Medicare Advocacy will be hosting a webinar to address benefits in the rapidly changing Medicare environment. Stay tuned for the scheduled date.
  • The Brigance Brigade Foundation (BBF) will soon launch the BBF Caregiver Club, which will be a virtual meetup of caregivers of people living with ALS (CALS). The Caregiver Club will encourage CALS to set aside time to practice self-care through guided activities such as art, journaling, meditation, and exercise. Email Amy Mullan at amullan@brigancebrigade.org to learn more and sign up.

Good News:

Know of a resource to support people affected by COVID-19 that we missed? Email us at AQ@augiesquest.org and we will include it once vetted.

Augie’s Quest 15th Annual BASH event returns to San Diego

By Champions

Media Contact:

Shannon K. Shryne, Augie’s Quest

Shannon@augiesquest.org and C: 619.791.5070

 

 

 

FOR IMMEDIATE RELEASE

 Augie’s Quest 15th Annual BASH event returns to San Diego

Nonprofit celebrates fitness industry commitment to finding a cure for ALS

 San Diego, February 7, 2020 – Augie’s Quest to Cure ALS, a nonprofit committed to changing the experience of thousands living with amyotrophic lateral sclerosis (ALS) by fast-tracking effective treatments and an ultimate cure, is celebrating their 15th BASH fundraiser by Rockin’ Through the Ages with the fitness industry on March 20.

Over 800 guests are expected to attend the event, which is held in conjunction with the International Health, Racquet and Sportsclub Association’s (IHRSA) International Tradeshow and Convention. The BASH represents an opportunity for the fitness industry to come together and celebrate advancements in ALS research, while reminding attendees of the critical hope their support offers for those affected by this disease.

“The fitness industry has made Augie’s Quest THEIR quest.  They’re focused on making our world healthier, and this passion for helping people has directly impacted every individual living with ALS,” said Augie Nieto, Co-Founder, Augie’s Quest to Cure ALS. “I’m proud to share the stage at this year’s BASH with the Chief Scientific Officer of the ALS Therapy Development Institute, Fernando Vieira, and fellow ALS Fighter Andrea Lytle Peet to share the incredible work we’re doing with the funds we’ve raised at the BASH.

This event is Presented by IHRSA and sponsored by Orangetheory Fitness, Jenny Craig, Newtown Athletic Club, The Atlantic Club, Zumba Fitness, Stone Creek Club & Spa, Club Automation, UFC Gym, Fitness Formula Clubs, Club Greenwood, Crunch Fitness, Hydromassage, North Castle Partners, Las Vegas Athletic Clubs and Planet Fitness, as well as others. The event will be emcee’d by international Zumba Education Specialist Loretta Bates, with entertainment provided by Australian raised Toby Rand, who is currently starring as a lead, in the hit “Broadway” musical ROCKTOPIA who previously appeared  on the CBS TV show Rockstar: Supernova with Tommy Lee, Jason Newstead, Gilby Clarke and Dave Navarro. The show was seen by over 20 million viewers each week and ended with RAND as runner-up and winning a signed record deal.

Just last month, the ALS Therapy Development Institute announced the naming of the Augie’s Quest Translational Research Center which will help to strengthen its existing and future research efforts by aiming to dissect mechanisms of clinical ALS and use the knowledge to develop new, more powerful drug discovery platforms and facilitate more effective drug development in ALS.

“In recent years, translational research has emerged as an increasingly important component of ALS TDI’s drug discovery,” says Fernando Vieira, Chief Scientific Officer, ALS TDI. “We owe much of our progress and ability to expand this transformative, essential research to Augie’s Quest. And, we are honored to celebrate this impact on our science with this special commendation.”

You can join the quest to end ALS at the 15th annual Bash by visiting augiesquest.org/bash.

About Augie’s Quest to Cure ALS

Augie’s Quest to Cure ALS is a nonprofit committed to changing the experience of people living with ALS by fast-tracking cutting-edge research to advance effective treatments and an ultimate cure. The organization is galvanizing thousands to join this fight, confronting ALS in an entirely new way, and driving innovative research forward, and at an accelerated pace. We are working to bring an exciting treatment, AT-1501, and many others, to market as fast as we can via our research partners at the ALS Therapy Development Institute. Augie’s Quest was co-founded more than a decade ago by Augie Nieto, the successful fitness industry mogul behind Lifecycle and Life Fitness who was diagnosed with ALS in 2005 and whose life story was recently chronicled in the award-winning film, Augie. With Augie’s Quest, ALS doesn’t stand a fighting chance. Because ALS isn’t incurable, it’s only underfunded. Please join our quest at www.augiesquest.org.

 

ALS won’t stop and neither will Augie’s Quest

Augie’s Quest to Cure ALS
PO Box #9886
Denver, CO 80209

T: 949-506-1007
E: AQ@augiesquest.org

Copyright © 2022 Augie's Quest. All Rights Reserved.